Search Results - "Bonar, Holly"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Automated Oxygen Gradient Ektacytometry: A Novel Biomarker in Sickle Cell Anemia by Sadaf, Alina, Seu, Katie G, Thaman, Elizabeth, Fessler, Rose, Konstantinidis, Diamantis G, Bonar, Holly A, Korpik, Jennifer, Ware, Russell E, McGann, Patrick T, Quinn, Charles T, Kalfa, Theodosia A

    Published in Frontiers in physiology (25-03-2021)
    “…Sickle cell anemia (SCA) is a hereditary hemoglobinopathy with a variable phenotype. There is no single biomarker that adequately predicts disease severity and…”
    Get full text
    Journal Article
  2. 2

    Sildenafil does not improve nitric oxide‐mediated endothelium‐dependent vascular responses in smokers by Dishy, Victor, Harris, Paul A., Pierce, Rosanna, Prasad, Harish C., Sofowora, Gbenga, Bonar, Holly L., Wood, Alastair J. J., Stein, C. Michael

    Published in British journal of clinical pharmacology (01-02-2004)
    “…Aims  To examine the hypothesis that sildenafil, a phosphodiesterase type 5 inhibitor that inhibits cGMP breakdown, could enhance nitric oxide‐mediated…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Pharmacokinetics-Guided Dosing of Hydroxyurea Can Achieve Near-Pancellular Fetal Hemoglobin Expression in Sickle Cell Anemia: F-Cell Analysis As a Benchmark for Disease-Modifying Therapy by Quinn, Charles T., Niss, Omar, Pfeiffer, Amanda, Korpik, Jennifer, Bonar, Holly, Reynaud, Mary, Ware, Russell E., McGann, Patrick T.

    Published in Blood (13-11-2019)
    “…▪ Background: Hydroxyurea is the standard of care for children with sickle cell anemia (SCA). We have developed and prospectively validated a population…”
    Get full text
    Journal Article
  5. 5